started · updated
Weight loss medication trends impact pharmacy logistics and clinical guidelines
The rise of weight loss medications, specifically GLP-1 receptor agonists, is driving significant shifts in both retail logistics and clinical recommendations. In Brazil, Grupo DPSP, which operates Drogaria São Paulo and Drogaria Pacheco, reports that approximately 70% of sales in this category are now conducted through digital channels. This surge in e-commerce requires specialized logistics to ensure proper storage, packaging, and transport of these sensitive products.
From a medical perspective, European health entities including EASO, EFAD, and ECPO have issued a consensus via The Lancet Diabetes & Endocrinology. The experts warn that rapid weight loss via these medications can lead to nutritional, muscular, and psychological risks if not managed with multidisciplinary support. The consensus emphasizes that clinical focus must shift from mere weight loss to the quality of weight loss, requiring oversight from doctors, nutritionists, psychologists, and physiotherapists to ensure patient health.
Entities
Drogaria Pacheco · Drogaria São Paulo · EASO · Grupo DPSP · The Lancet Diabetes & Endocrinology